Added to YB: 2025-06-04
Pitch date: 2025-06-02
MEDP [neutral]
Medpace Holdings, Inc.
+87.3%
current return
Author Info
FluentInQuality invests in high-quality businesses that generate steady and sustainable cashflows, proven track records, and the potential to act as a true compounding machines over the long run. Sign up for the newsletter.
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Market Cap
$15.4B
Pitch Price
$297.86
Price Target
N/A
Dividend
N/A
EV/EBITDA
26.28
P/E
38.18
EV/Sales
6.44
Sector
Life Sciences Tools and Services
Category
growth
High-Quality Mid-Caps You Need To Monitor Closely In 2025 - Medpace Holdings, Inc.
MEDP (quick overview): Full-service CRO with integrated model outperforms fragmented competitors. Founder-led, disciplined with 25-30% operating margins, high ROIC, minimal debt. Long-term client retention creates steady revenue growth. Industry tailwinds: biotech funding, complex global trials, stricter regulations. Cash-generating engine in healthcare picks-and-shovels space.
Read full article (2 min)